Spots Global Cancer Trial Database for Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Official Title: Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Study ID: NCT00592163
Interventions
ZIO-101-C (Darinaparsin)
Study Description
Brief Summary: A Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and Lymphomas
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, Montreal, Quebec, Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
